263 related articles for article (PubMed ID: 25284748)
1. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
Day E; Waters B; Spiegel K; Alnadaf T; Manley PW; Buchdunger E; Walker C; Jarai G
Eur J Pharmacol; 2008 Dec; 599(1-3):44-53. PubMed ID: 18938156
[TBL] [Abstract][Full Text] [Related]
4. Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Li Y; Lu X; Ren X; Ding K
J Med Chem; 2015 Apr; 58(8):3287-301. PubMed ID: 25569119
[TBL] [Abstract][Full Text] [Related]
5. Collagen recognition and transmembrane signalling by discoidin domain receptors.
Carafoli F; Hohenester E
Biochim Biophys Acta; 2013 Oct; 1834(10):2187-94. PubMed ID: 23128141
[TBL] [Abstract][Full Text] [Related]
6. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
Abdulhussein R; McFadden C; Fuentes-Prior P; Vogel WF
J Biol Chem; 2004 Jul; 279(30):31462-70. PubMed ID: 15136580
[TBL] [Abstract][Full Text] [Related]
7. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
Valiathan RR; Marco M; Leitinger B; Kleer CG; Fridman R
Cancer Metastasis Rev; 2012 Jun; 31(1-2):295-321. PubMed ID: 22366781
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
Leitinger B
J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
[TBL] [Abstract][Full Text] [Related]
9. Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship.
Shenoy GP; Pal R; Purwarga Matada GS; Singh E; Raghavendra NM; Dhiwar PS
Bioorg Chem; 2023 Jan; 130():106215. PubMed ID: 36384067
[TBL] [Abstract][Full Text] [Related]
10. Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling.
Carafoli F; Mayer MC; Shiraishi K; Pecheva MA; Chan LY; Nan R; Leitinger B; Hohenester E
Structure; 2012 Apr; 20(4):688-97. PubMed ID: 22483115
[TBL] [Abstract][Full Text] [Related]
11. Discoidin Domain Receptor 1 Inhibitors: Advances and Future Directions for Novel Therapeutics with Aid of DNA Encoded Library Screens and Artificial Intelligence.
Sanawar R; Sahayasheela VJ; Sarath P; Dan VM
Mini Rev Med Chem; 2023; 23(15):1507-1513. PubMed ID: 36698236
[TBL] [Abstract][Full Text] [Related]
12. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.
Xu H; Raynal N; Stathopoulos S; Myllyharju J; Farndale RW; Leitinger B
Matrix Biol; 2011 Jan; 30(1):16-26. PubMed ID: 21044884
[TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor functions in physiological and pathological conditions.
Leitinger B
Int Rev Cell Mol Biol; 2014; 310():39-87. PubMed ID: 24725424
[TBL] [Abstract][Full Text] [Related]
14. Identification of type II and III DDR2 inhibitors.
Richters A; Nguyen HD; Phan T; Simard JR; Grütter C; Engel J; Rauh D
J Med Chem; 2014 May; 57(10):4252-62. PubMed ID: 24754677
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.
Rix U; Remsing Rix LL; Terker AS; Fernbach NV; Hantschel O; Planyavsky M; Breitwieser FP; Herrmann H; Colinge J; Bennett KL; Augustin M; Till JH; Heinrich MC; Valent P; Superti-Furga G
Leukemia; 2010 Jan; 24(1):44-50. PubMed ID: 19890374
[TBL] [Abstract][Full Text] [Related]
16. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
Ruiz PA; Jarai G
J Biol Chem; 2011 Apr; 286(15):12912-23. PubMed ID: 21335558
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors.
Gao M; Duan L; Luo J; Zhang L; Lu X; Zhang Y; Zhang Z; Tu Z; Xu Y; Ren X; Ding K
J Med Chem; 2013 Apr; 56(8):3281-95. PubMed ID: 23521020
[TBL] [Abstract][Full Text] [Related]
18. Normal activation of discoidin domain receptor 1 mutants with disulfide cross-links, insertions, or deletions in the extracellular juxtamembrane region: mechanistic implications.
Xu H; Abe T; Liu JK; Zalivina I; Hohenester E; Leitinger B
J Biol Chem; 2014 May; 289(19):13565-74. PubMed ID: 24671415
[TBL] [Abstract][Full Text] [Related]
19. Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1.
Abdulhussein R; Koo DH; Vogel WF
J Biol Chem; 2008 May; 283(18):12026-33. PubMed ID: 18065762
[TBL] [Abstract][Full Text] [Related]
20. Discoidin domain receptors: structural relations and functional implications.
Vogel W
FASEB J; 1999; 13 Suppl():S77-82. PubMed ID: 10352148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
